Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review

doi:10.5306/wjco.v11.i1.31

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8356)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

593

WORD

218

HTML

5590

Figures (1-3)

334

Tables (1-2)

245

Sum=6980

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

658

Download

718

Sum=1376

Jan 24, 2020 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Review

World J Clin Oncol. Jan 24, 2020; 11(1): 31-42
Published online Jan 24, 2020. doi: 10.5306/wjco.v11.i1.31

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow diagram of articles identification and selection. BRAF: B-raf proto-oncogene serine/threonine kinase.

Open in New Tab Full Size Figure Download Figure

Figure 2 Anatomic location of B-raf proto-oncogene serine/threonine kinase V600E additional mutations. a, b: Additional mutations of the same ameloblastomas. Figure does not represent the specific site of each additional mutation, only whether it is present in the maxilla or the mandible.

Open in New Tab Full Size Figure Download Figure

Figure 3 Mutation distribution and relationship with pathological features. Information on histology and anatomical site is included below for each case. NS: No specified. BRAF WT: B-raf proto-oncogene serine/threonine kinase wild-type.

Citation: González-González R, López-Verdín S, Lavalle-Carrasco J, Molina-Frechero N, Isiordia-Espinoza M, Carreón-Burciaga RG, Bologna-Molina R. Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review. World J Clin Oncol 2020; 11(1): 31-42
URL: https://www.wjgnet.com/2218-4333/full/v11/i1/31.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i1.31